Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage

European Journal of Pharmacology

Volumn 315, Issue 1, 1996, Pages 19-30

  Semkova, Irina ^a   Wolz, Philipp ^a   Schilling, Matthias ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Astrocyte, cultured; Cerebral ischemia; Excitotoxicity; Hippocampal cell; Nerve growth factor (NGF); Protection; Selegiline

Indexed keywords

GLUTAMIC ACID; MONOAMINE OXIDASE B INHIBITOR; NERVE GROWTH FACTOR; SELEGILINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL CORTEX; GLUTAMIC ACID; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; RNA, MESSENGER; SELEGILINE;

EID: 0030574241     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00593-6     Document Type: Article

References (62)

1. +-neurotoxicity against rat dopaminergic neurons in culture. Neurosci. Lett. 193, 53.
2. Ansari, K.S., P.H. Yu, T.P.A. Kruck and W.G. Tatton, 1993, Rescue of axotomized immature rat-facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition, J. Neurosci. 13, 1043.
3. Ayer-LeLievre, C., L. Olson, T. Ebendal, A. Seiger and H. Persson, 1988, Expression of the β-nerve growth factor gene in hippocampal neurons, Science 240, 1339.
4. Backhauß, C., C. Karkoutly, M. Welsch and J. Krieglstein, 1992, A mouse model of focal cerebral ischemia for screening neuroprotective drug effects, J. Pharmacol. Methods 27, 27.
5. Biagini, G., M. Zoli, K. Fuxe and L.F. Agnati, 1993, L-Deprenyl increases GFAP immunoreactivity selectively in activated astrocytes in rat brain, NeuroReport 4, 955.
6. Biagini, G., A. Frasoldati, K. Fuxe and L.F. Agnati, 1994, The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: evidence for L-deprenyl-induced activation of reactive astrocytes, Neurochem. Int. 25, 17.
7. Birkmayer, W., J. Knoll, P. Riederer, V. Hars and J. Marton, 1985, Increased life expectancy resulting from addition of L-deprenyl to madopar treatment in Parkinson's disease: a long term study, J. Neural. Transm. 64, 113.
8. Carrillo, M.C., K. Kitani, S. Kanai, Y. Sato and G.O. Ivy, 1992, The activity of ( - )-deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective. Life Sci. 50, 1985.
9. Carswell, S., 1993, The potential for treating neurodegenerative disorders with NGF-inducing compounds, Exp. Neurobiol. 124, 36.
10. Cellerino, A., 1996, Expression of messenger RNA coding for the nerve growth factor receptor trkA in the hippocampus of the adult rat, Neuroscience 70, 613.
11. Cheng, B. and M.P. Mattson, 1991, NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis, Neuron 7, 1031.
12. De Kosky, S.T., J.R. Goss, P.D. Miller, S.D. Styren, P.M. Kochanek and D. Marion, 1994, Upregulation of nerve growth factor following cortical trauma. Exp. Neurol. 130, 173.
13. Eclancher, F., F. Perraud, J. Faltin, G. Labourdette and M. Sensenbrenner, 1990, Reactive astrogliosis after basic fibroblast growth factor (bFGF) injection in injured neonatal rat brain, Glia 3, 502.
14. Finnegan, K.T., J.J. Skratt, I. Irwin, L.E. DeLanney and J.W. Langston, 1990, Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO-B, Eur. J. Pharmacol. 184, 119.
15. Fowler, C.J., B.A. Callingham, T.J. Mantle and K.F. Tipton, 1978, Monoamine oxidase A and B: a useful concept?, Biochem. Pharmacol. 27, 97.
16. Gall, C.M. and P.J. Isackson, 1989, Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 245, 758.
17. Giulian, D., K. Vaca and M. Corpuz, 1993, Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29.
18. Greenamyre, J.T. and A.B. Young, 1989, Excitatory amino acids and Alzheimer's disease, Neurobiol. Aging 10, 593.
19. Grothe, C. and K. Unsicker, 1992, Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic and lesion-related responses, J. Neurosci. Res. 32, 317.
20. Hefti, F., A. Dravid and J. Hartikka, 1984, Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions, Brain Res. 293, 305.
21. Houlgatte, R., M. Mallat, P. Brachet and A. Prochiantz, 1989, Secretion of nerve growth factor in cultures of glial cells and neurons derived from different regions of the mouse brain, J. Neurosci. Res. 24, 143.
22. Hutton, L.A. and J.R. Perez-Polo, 1995, In vitro glial responses to nerve growth factor, J. Neurosci. Res. 41, 185.
23. Ip, N.Y., Y. Li, G.D. Yancopoulos and R.M. Lindsay, 1993, Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF, J. Neurosci. 13, 3394.
24. Iwasaki, Y., K. Ikeda, T. Shiojima, T. Kobayashi, N. Tagaya and M. Kinoshita, 1994, Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons, J. Neurol. Sci. 125, 11.
25. Ju, W.Y.H., D.P. Holland and W.G. Tatton, 1994, ( - )-Deprenyl alters the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats, Exp. Neurol. 126, 233.
26. Knollema, S., W. Aukema, H. Hom, J. Korf and G.J. Ter Horst, 1995, L-Deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia, Stroke 20, 1883.
27. Koh, J.I. and D.W. Choi, 1988, Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase, J. Neurosci. 8, 2153.
28. Korsching, S. and H. Thoenen, 1983, Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation, Proc. Natl. Acad. Sci. USA 80, 3513.
29. +-treated dopaminergic neurons, Eur. J. Pharmacol. Mol. Pharmacol. Sec. 269, R3.
30. Lärkfors, L., I. Strömberg, T. Ebendal and L. Olson, 1987, Nerve growth factor protein level increases in the adult rat hippocampus after a specific cholinergic lesion, J. Neurosci. Res. 18, 525.
31. Lee, T.-H., K. Abe, K. Kogure and Y. Itoyama, 1995, Expressions of nerve growth factor and p75 low affinity receptor after transient forebrain ischemia in gerbil hippocampal CA1 neurons, J. Neurosci. Res. 41, 684.
32. Levison, S.W. and K.D. McCarthy, 1991, Characterization and partial purification of AIM: a plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors, J. Neurochem. 57, 782.
33. Lique, J.M., S.-W. Kwan, C.W. Abell, M. Da Prada and J.G. Richards, 1995, Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system, J. Comp. Neurol. 363, 665.
34. Lorez, H., F. Keller, G. Ruess and U. Otten, 1989, Nerve growth factor increases in adult rat brain after hypoxic injury, Neurosci. Lett. 98, 339.
35. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons, J. Neurochem. 65, 1740.
36. Mattson, M.P. and S.W. Scheff, 1994, Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy, J. Neurotrauma 11, 3.
37. McCarthy, K.D. and J. DeVellis, 1980, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell. Biol. 85, 890.
38. Mocchetti, I., 1991, Theoretical basis for a pharmacology of nerve growth biosynthesis, Annu. Rev. Pharmacol. Toxicol. 32, 303.
39. Olney, J.W., C.F. Zorumski, M.T. Price, G.G. Wang and J. Labruyere, 1990, Excitotoxicity of L-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's diseases, Exp. Neurol. 108, 269.
40. Pechan, P.A., T. Yoshida, N. Panahian, M.A. Moskowitz and X.O. Breakefield, 1995, Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat, NeuroReport 6, 669.
41. Rabizadeh, S., C.M. Bitler, L.L. Butcher and D.E. Bredesen, 1994, Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity, Proc. Natl. Acad. Sci. USA 91, 10703.
42. Salo, P.T. and W.G. Tatton, 1992, Deprenyl reduces the death of motoneurons caused by axotomy, J. Neurosci. Res. 31, 394.
43. Sambrook, J., E.F. Fritsch and T. Maniatis, 1989, Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) p. 456.
44. Schmalenbach, C. and H.W. Müller, 1993, Astroglia-neuron interactions that promote long-term neuronal survival, J. Chem. Neuroanat. 6, 229.
45. Semkova, I. and J. Krieglstein, 1995, Induction of NGF in rat cortical astrocytes by isoproterenol, clenbuterol and selegiline, J. Cereb. Blood Flow Metab. 15, S573.
46. Sendtner, M., G.W. Kreutzberg and H. Thoenen, 1990, Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy, Nature 345, 440.
47. Seniuk, N.A., J.T. Henderson, W.G. Tatton and J.C. Roder, 1994, Increased CNTF gene expression in process-bearing astrocytes following injury is augmented by R ( - )-deprenyl, J. Neurosci. Res. 37, 278.
48. Shelton, D.L. and L.F. Reichardt, 1986. Studies on the expression of the β-nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggests that NGF functions as a trophic factor for several distinct populations of neurons, Proc. Natl. Acad. Sci. USA 83, 2714.
49. Simon, R.P., J.H. Swans, T. Griffith and B.S. Meldrum, 1984, Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain, Science 226, 850.
50. Sivenius, J,. J. Kuhmonen, R. Meittinen, A. Baapalinna and P.J. Reikkinen, 1994, Effect of selegiline on CA1 layer following transient ischemia in gerbil, Soc. Neurosci. Abstr. 20, 83,5.
51. Sofroniew, M.V. and J.D. Cooper, 1993, Neurotrophic mechanisms and neuronal degeneration, Semin. Neurosci. 5, 285.
52. Stoll, S., U. Hafner, O. Pohl and W.E. Müller, 1994, Age-related memory decline and longevity under treatment with selegiline. Life Sci. 55, 2155.
53. 14C]-iodoantipyrine autoradiography following middle cerebral artery occlusion, J. Cereb. Blood Flow Metab. 1, 61.
54. Tatton, W.G., 1993. Selegiline can mediate neuronal rescue rather than neuronal protection, Mov. Disord. 8 (Suppl. 1), S20.
55. Tatton, W.G. and C.E. Greenwood, 1991. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res. 30, 666.
56. Tatton, W.G., W.Y.L. Ju, D.P. Holland, C. Tai and M. Kwan, 1994a, ( - )-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis, J. Neurochem. 63, 1572.
57. Tatton, W.G., N. Seniuk, K. Ansari, W. Ju, F. Zhang, V. MacMillan, G. Liu, M. Kwan, H. Huang, P. Salo and D. Holland, 1994b. Trophic-like' rescue of dying neurons by ( - )-deprenyl or pargiline independent of MAO inhibition, in: Advances in the Treatment of Neurodegenerative Disorders, eds. G. Racagni, N. Brunello and S.Z. Langer (Karger, Basel) p. 238.
58. Welsh, F.A., T. Sakamoto, A.E. McKee and R.E. Sims, 1987, Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain, J. Neurochem. 49. 846.
59. Whittemore, S.R., P.L. Friedman, D. Larhammar, H. Persson, M. Gonzales-Carvajal and V.R. Holets, 1988, Rat-beta nerve growth factor sequence and site of synthesis in the adult hippocampus, J. Neurosci. Res. 20. 403.
60. Whittemore, S.R. and A. Seiger, 1987, The expression, localization and functional significance of β-nerve growth factor in the central nervous system, Brain Res. Rev. 12, 439.
61. Yamamoto, S., T. Yoshimine, T. Fujita, R. Kuroda, T. Irie, K. Fujioka and K. Hayakawa, 1992, Protective effect of NGF atelocollagen mini-pellet on hippocampal delayed neuronal death in gerbils, Neurosci. Lett. 141. 161.
62. Zeng, Y.C., S. Bongrani, E. Bronzetti, S. Cadel, A. Ricci, B. Valsecchi and F. Amenta, 1995, Effect of long-term treatment with L-deprenyl on the age-dependent microanatomical changes in the rat hippocampus, Mech. Aging Dev. 79, 169.